These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 12384979)
1. K vitamins, PTP antagonism, and cell growth arrest. Carr BI; Wang Z; Kar S J Cell Physiol; 2002 Dec; 193(3):263-74. PubMed ID: 12384979 [TBL] [Abstract][Full Text] [Related]
2. Involvement of hepatocyte epidermal growth factor receptor mediated activation of mitogen-activated protein kinase signaling pathways in response to growth inhibition by a novel K vitamin. Wang Z; Wang M; Carr BI J Cell Physiol; 2000 Jun; 183(3):338-46. PubMed ID: 10797308 [TBL] [Abstract][Full Text] [Related]
3. Tumor cell growth inhibition and extracellular signal-regulated kinase (ERK) phosphorylation by novel K vitamins. Osada S; Osada K; Carr BI J Mol Biol; 2001 Dec; 314(4):765-72. PubMed ID: 11733995 [TBL] [Abstract][Full Text] [Related]
4. Cdc25 inhibition and cell cycle arrest by a synthetic thioalkyl vitamin K analogue. Tamura K; Southwick EC; Kerns J; Rosi K; Carr BI; Wilcox C; Lazo JS Cancer Res; 2000 Mar; 60(5):1317-25. PubMed ID: 10728693 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of rat liver regeneration after partial hepatectomy and induction of ERK phosphorylation by Cpd 5, a K vitamin-based anticancer compound. Kar S; Wang M; Rosi KS; Wilcox CS; Carr BI Carcinogenesis; 2004 Dec; 25(12):2345-51. PubMed ID: 15319298 [TBL] [Abstract][Full Text] [Related]
6. Involvement of Cdc25A phosphatase in Hep3B hepatoma cell growth inhibition induced by novel K vitamin analogs. Wang Z; Southwick EC; Wang M; Kar S; Rosi KS; Wilcox CS; Lazo JS; Carr BI Cancer Res; 2001 Oct; 61(19):7211-6. PubMed ID: 11585757 [TBL] [Abstract][Full Text] [Related]
7. Growth inhibition and protein tyrosine phosphorylation in MCF 7 breast cancer cells by a novel K vitamin. Kar S; Carr BI J Cell Physiol; 2000 Dec; 185(3):386-93. PubMed ID: 11056008 [TBL] [Abstract][Full Text] [Related]
8. Fluorinated Cpd 5, a pure arylating K-vitamin derivative, inhibits human hepatoma cell growth by inhibiting Cdc25 and activating MAPK. Kar S; Wang M; Ham SW; Carr BI Biochem Pharmacol; 2006 Nov; 72(10):1217-27. PubMed ID: 16930563 [TBL] [Abstract][Full Text] [Related]
9. EGFR-independent activation of ERK1/2 mediates growth inhibition by a PTPase antagonizing K-vitamin analog. Kar S; Adachi T; Carr BI J Cell Physiol; 2002 Mar; 190(3):356-64. PubMed ID: 11857451 [TBL] [Abstract][Full Text] [Related]
10. Hepatocyte growth factor enhances protein phosphatase Cdc25A inhibitor compound 5-induced hepatoma cell growth inhibition via Akt-mediated MAPK pathway. Wang Z; Wang M; Carr BI J Cell Physiol; 2005 Jun; 203(3):510-9. PubMed ID: 15534860 [TBL] [Abstract][Full Text] [Related]
11. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway. Wang Z; Ge L; Wang M; Carr BI J Cell Physiol; 2006 Jul; 208(1):133-40. PubMed ID: 16596619 [TBL] [Abstract][Full Text] [Related]
12. Critical role of extracellular signal-regulated kinase phosphorylation on menadione (vitamin K3) induced growth inhibition. Osada S; Saji S; Osada K Cancer; 2001 Mar; 91(6):1156-65. PubMed ID: 11267961 [TBL] [Abstract][Full Text] [Related]
13. Binding and inhibition of Cdc25 phosphatases by vitamin K analogues. Kar S; Lefterov IM; Wang M; Lazo JS; Scott CN; Wilcox CS; Carr BI Biochemistry; 2003 Sep; 42(35):10490-7. PubMed ID: 12950176 [TBL] [Abstract][Full Text] [Related]
14. Skin cancer chemopreventive effects of a flavonoid antioxidant silymarin are mediated via impairment of receptor tyrosine kinase signaling and perturbation in cell cycle progression. Ahmad N; Gali H; Javed S; Agarwal R Biochem Biophys Res Commun; 1998 Jun; 247(2):294-301. PubMed ID: 9642119 [TBL] [Abstract][Full Text] [Related]
15. Involvement of c-Myc in growth inhibition of Hep 3B human hepatoma cells by a vitamin K analog. Ge L; Wang Z; Wang M; Kar S; Carr BI J Hepatol; 2004 Nov; 41(5):823-9. PubMed ID: 15519656 [TBL] [Abstract][Full Text] [Related]
16. 2-Methoxyestradiol inhibits hepatocellular carcinoma cell growth by inhibiting Cdc25 and inducing cell cycle arrest and apoptosis. Kar S; Wang M; Carr BI Cancer Chemother Pharmacol; 2008 Oct; 62(5):831-40. PubMed ID: 18246350 [TBL] [Abstract][Full Text] [Related]
17. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells. Lee LT; Huang YT; Hwang JJ; Lee PP; Ke FC; Nair MP; Kanadaswam C; Lee MT Anticancer Res; 2002; 22(3):1615-27. PubMed ID: 12168845 [TBL] [Abstract][Full Text] [Related]
18. Antitumor and anticarcinogenic actions of Cpd 5: a new class of protein phosphatase inhibitor. Kar S; Wang M; Wilcox CS; Carr BI Carcinogenesis; 2003 Mar; 24(3):411-6. PubMed ID: 12663499 [TBL] [Abstract][Full Text] [Related]
19. Modulation of bcl-2 family proteins in MAPK independent apoptosis induced by a cdc25 phosphatase inhibitor Cpd 5 in renal cancer cells. Mizuno R; Oya M; Hara S; Matsumoto M; Horiguchi A; Ohigashi T; Marumo K; Murai M Oncol Rep; 2005 Sep; 14(3):639-44. PubMed ID: 16077967 [TBL] [Abstract][Full Text] [Related]
20. The protein kinase C inhibitor Go6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] potentiates agonist-induced mitogen-activated protein kinase activation through tyrosine phosphorylation of the epidermal growth factor receptor. Shah BH; Olivares-Reyes JA; Catt KJ Mol Pharmacol; 2005 Jan; 67(1):184-94. PubMed ID: 15465928 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]